Abstract Details

Title Accuracy and diagnosis cutoff points of 123I-metaiodobenzylguanidine myocardial scintigraphy for Lewy body disease diagnoses in parkinsonian syndromes: a study of 62 consecutive patients in an expert center.

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 070

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Guillaume Lamotte, MD PRESENTER	Dr. Lamotte has nothing to disclose.
	No disclosure on file
	No disclosure on file
Gilles Defer, MD (Hopital Cote De Nacre)	Dr. Defer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
	No disclosure on file